Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Delcath names new board member
Dr Contag founded Cobalt Technologies in 2006 and served as CEO. Prior to starting Cobalt, Dr Contag founded Xenogen, a biotechnology company. Dr Contag received her PhD in
Dr Contag founded Cobalt Technologies in 2006 and served as CEO. Prior to starting Cobalt, Dr Contag founded Xenogen, a biotechnology company. Dr Contag received her PhD in
Study 304 successfully met its primary endpoint of a statistically significant reduction in summed pain intensity differences from baseline over 24 hours (SPID24) for Acetavance 1000mg compared to
The interim analysis conducted by the Data Safety Monitoring Board (DSMB) evaluated stroke patients’ outcome 90 days following an acute ischemic stroke, comparing treatment with Viprinex to treatment
In the proposed trial Hemopure would be studied for use in the treatment of anemia secondary to induction chemotherapy in patients with acute myeloid leukemia (AML) who refuse
The CE Marking ensures the free movement of Biostep within the European Free Trade Association (with the exception of Switzerland) and EU single market (total 28 countries). Biostep
The Cozart line, which will be exclusively distributed by Merck Specialities in India, includes the Cozart Drug Detection System (DDS) that is said to be the fastest, most
Under the terms of the agreement, Philusa will have exclusive rights to the marketing and distribution of Lescarden’s Repliderm burn relief line of consumer products for cuts, minor
The Handel study is a double-blind, placebo-controlled, randomized clinical trial that will investigate the efficacy and safety of alitretinoin in the treatment of severe chronic hand eczema (CHE)
The enhanced PrimaCare ONE replaces the previous formulation, immediately becoming the most comprehensive one-capsule-per day omega-3 prescription prenatal vitamin in the market and providing unmatched prenatal and postnatal
Chengxuan will make a payment to the company upon the closing of the sale and two other payments during the year after the closing. Chengxuan is owned by